Pharmanutra S.p.A. Depreciation And Amortization for the year ending December 31, 2024: USD 4.07 M

Pharmanutra S.p.A. Depreciation And Amortization is USD 4.07 M for the year ending December 31, 2024, a 52.50% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Pharmanutra S.p.A. Depreciation And Amortization for the year ending December 31, 2023 was USD 2.67 M, a 117.95% change year over year.
  • Pharmanutra S.p.A. Depreciation And Amortization for the year ending December 31, 2022 was USD 1.22 M, a -22.59% change year over year.
  • Pharmanutra S.p.A. Depreciation And Amortization for the year ending December 31, 2021 was USD 1.58 M, a -44.64% change year over year.
  • Pharmanutra S.p.A. Depreciation And Amortization for the year ending December 31, 2020 was USD 2.86 M, a 161.56% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased